Lung Cancer Trial, By Invitation NCT06997458 Sponsor: Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06997458
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are older than 18 years of age.
  • People of any gender.
  • People who are able to read and sign a written consent form agreeing to take part.
  • People who have been diagnosed with advanced non-small cell lung cancer (a type of lung cancer), specifically stage IV, based on an internationally recognised staging system for lung cancer.
  • People whose lung cancer has been confirmed through a tissue sample to be a specific type called adenocarcinoma.
  • People with lung cancer who have a general health and activity level rated as 0, 1, or 2 on a standard scale used by doctors (this roughly means someone who is fully active, has some limitations but can care for themselves, or is up and about more than half their waking hours).
  • People with lung cancer who are expected to live for at least 3 months.
  • People with lung cancer who have not yet received any cancer treatment, including chemotherapy, immunotherapy, targeted therapy, or radiotherapy.
  • People with lung cancer who are smokers or non-smokers.
  • People who have been diagnosed with advanced colorectal cancer (bowel cancer), specifically stage IV, based on an internationally recognised staging system for colorectal cancer.
  • People whose colorectal cancer has been confirmed through a tissue sample to be a specific type called adenocarcinoma.
  • People with colorectal cancer who have a general health and activity level rated as 0, 1, or 2 on the standard scale described above.
  • People with colorectal cancer who are expected to live for at least 3 months.
  • People with colorectal cancer who have not yet received any cancer treatment, including chemotherapy, immunotherapy, targeted therapy, or radiotherapy.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had any other type of cancer in the past 5 years, except for certain common skin cancers (non-melanoma skin cancer).
  • People who are unable or unwilling to provide written consent to take part in the trial.
  • People who are pregnant or currently breastfeeding.
  • People who have small cell lung cancer (a different type of lung cancer from the one this trial is studying).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
30 July 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

To analyse the impact of adopting large (TEMPUS) NGS panels in the real world of the Andalusian Health Public System in terms of impact on clinical practice and cost.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov